Related Experiment Video
Updated: Jan 5, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Physiological and pathological roles of LRRK2 in the nuclear envelope integrity
Vered Shani1, Hazem Safory1, Raymonde Szargel1
1Dept. of Biochemistry, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Abstract:
Mutations in LRRK2 cause autosomal dominant and sporadic Parkinson's disease, but the mechanisms involved in LRRK2 toxicity in PD are yet to be fully understood. We found that LRRK2 translocates to the nucleus by binding to seven in absentia homolog (SIAH-1), and in the nucleus it directly interacts with lamin A/C, independent of its kinase activity. LRRK2 knockdown caused nuclear lamina abnormalities and nuclear disruption. LRRK2 disease mutations mostly abolish the interaction with lamin A/C and, similar to LRRK2 knockdown, cause disorganization of lamin A/C and leakage of nuclear proteins. Dopaminergic neurons of LRRK2 G2019S transgenic and LRRK2 -/- mice display decreased circularity of the nuclear lamina and leakage of the nuclear protein 53BP1 to the cytosol. Dopaminergic nigral and cortical neurons of both LRRK2 G2019S and idiopathic PD patients exhibit abnormalities of the nuclear lamina. Our data indicate that LRRK2 plays an essential role in maintaining nuclear envelope integrity. Disruption of this function by disease mutations suggests a novel phosphorylation-independent loss-of-function mechanism that may synergize with other neurotoxic effects caused by LRRK2 mutations.
Insights
Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) disrupt nuclear envelope integrity in Parkinson's disease. This novel loss-of-function mechanism, independent of kinase activity, contributes to neurodegeneration.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are linked to autosomal dominant and sporadic Parkinson's disease (PD).
- The precise mechanisms underlying LRRK2 toxicity in PD remain incompletely understood.
Purpose of the Study:
- To investigate the role of LRRK2 in nuclear function and its potential involvement in PD pathogenesis.
- To elucidate the interaction of LRRK2 with nuclear components and the impact of disease mutations.
Main Methods:
- Studied LRRK2 translocation to the nucleus via binding to seven in absentia homolog (SIAH-1).
- Examined LRRK2 interaction with lamin A/C, nuclear lamina integrity, and nuclear protein localization in cell and animal models, including PD patient neurons.
Main Results:
- LRRK2 binds to SIAH-1 and interacts with lamin A/C in the nucleus, independent of kinase activity.
- LRRK2 knockdown or disease mutations disrupt nuclear lamina integrity, leading to nuclear abnormalities and protein leakage.
- Abnormalities in nuclear lamina structure and nuclear protein 53BP1 leakage were observed in dopaminergic neurons from LRRK2 mutant mice and PD patients.
Conclusions:
- LRRK2 plays a critical role in maintaining nuclear envelope integrity.
- Disease-associated LRRK2 mutations may cause PD through a phosphorylation-independent loss-of-function mechanism affecting nuclear structure.
- This disruption of nuclear integrity could synergize with other LRRK2-related neurotoxic pathways in Parkinson's disease.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Regulation of the Unfolded Protein Response
Lysosomal Hydrolases
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...

